• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cerner Integrates Surescripts Prescription Price Transparency Functionality With EHR

by Jasmine Pennic 02/22/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Is Defensive Medicine Driving Up Healthcare Costs

Cerner has announced a collaboration with Surescripts to integrate their Real-Time Prescription Benefit functionality into the Cerner Millennium electronic health record (EHR). Surescripts Real-Time Prescription Benefit will integrate directly into the physician’s workflow to provide patient-specific prescription information at the point of care.

Prescription benefit information at the point of care will help facilitate engagement between individuals and their physicians to find the prescription that fits their needs at the right price. Within Cerner Millennium, Real-Time Prescription Benefit renders prescription price transparency by leveraging information from pharmacy benefit managers that represent nearly two-thirds of U.S. patients. For people whose plans are connected, the functionality can provide the patient’s out-of-pocket cost for the selected prescription as well as identify therapeutic alternatives and patient specific coverage alerts such as prior authorization flags, quantity restrictions, deductibles and step therapy requirements. This information at the point of care can help avoid potential “sticker shock” at the pharmacy, improving medication adherence and building stronger relationships between person and physician.

As part of the collaboration, Cerner clients will now be able to integrate Real-Time Prescription Benefit into Cerner Millennium, with the first health systems implementing the prescription price transparency functionality starting in March 2018. The functionality will be added to CernerePrescribe, enabled seamlessly within the clinical workflow and free of charge for all clients. Health systems that choose to enable the functionality will provide doctors with prescription information to discuss with patients and their families right in the examination room, doctor’s office, clinic or wherever care may be provided.

“Cerner and Surescripts are transforming prescription price transparency at the point of care to improve the consumer and provider experience,” said Zane Burke, president, Cerner in a statement. “Each person needs to be at the center of their own health and care. With this new functionality in the EHR, not only will people have added visibility to their choices of prescriptions, but individuals can work together with their physicians to create a medication plan they can adhere to and afford.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Cerner, Cerner Millennium, Drug-Price Transparency, Healthcare Price Transparency, Surescripts

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |